As such, today the TSPO is a validated target for a number of therapeutic applications for neurological and psychiatric disorders [8,9], neurodegenerative diseases, traumatic brain injuries and strokes [10]; a therapeutic target in neurotrauma [11]; and a highly investigated target for the development of neuroprotective drugs [8,10]. The gene discussed is TSPO; the disease is stroke disorder.